[Annotation] IMP or IGI for deficiencies
Doug howe
dhowe at cs.uoregon.edu
Fri Nov 7 12:32:39 PST 2008
Agree all around.
Thx.
Karen Christie wrote:
> Hi Doug,
>
> Yes, I think that in some cases I just wouldn't be comfortable making
> an annotation from a multiple deficiency for the reasons you state,
> that you may not know which gene(s) were causing the effect. In the
> cases where you say that they rescue by re-introducing specific genes,
> I think you can use IMP if they show that the phenotype is specific to
> the one gene being annotated.
>
> I should also add that sometimes I am annotating from strains where it
> is known that there are background mutations, usually markers
> (typically auxotrophies, genes required for synthesis of histidine,
> uracil, etc.), but that these genes do not affect the phenotype that
> the GO annotation is based on. I ignore these for the purpose of
> deciding between IMP and IGI.
>
> -Karen
>
>
>
>
> On Fri, 7 Nov 2008, Doug howe wrote:
>
>> Hi Karen,
>> If a deficiency affects multiple gene, making any annotation is of
>> course dependent upon your ability to discern which gene(s) may be
>> involved in whatever you are annotating. I guess it would typically
>> be difficult to make any annotation with a Df mutant for that
>> reason. There are a few cases in zebrafish where a phenotype was
>> rescued by re-introducing specific genes that were lost in the Df..so
>> you at least think you know what gene to annotate.
>>
>> -Doug
>>
>> Karen Christie wrote:
>>> Hi,
>>>
>>> I think I'd be likely to use IGI for a "a deficiency mutant which is
>>> known to affect more than one gene", barring some extenuating
>>> circumstance.
>>>
>>> Generally, I use IMP for a single mutant affecting the gene of
>>> interest, and IGI for most other genetic situations I can think of,
>>> e.g. double or triple mutants, or a single mutant NOT in the gene
>>> being annotated (as per GO guidelines which specify that making an
>>> annotation for gene A based on a single mutation in gene B is IGI).
>>>
>>> -Karen
>>>
>>> On Fri, 7 Nov 2008, Doug howe wrote:
>>>
>>>> If an experiment uses a deficiency mutant which is known to affect
>>>> more than one gene, should that be curated for GO using IMP or
>>>> IGI? Contrast that with basically the same experiment where the
>>>> same genes were targeted individually with morpholinos/antisense
>>>> techniques...the latter seems like IGI.
>>>> ?
>>>>
>>>> --
>>>> Doug Howe, Ph.D.
>>>> ZFIN Scientific Curator
>>>> Zebrafish Nomenclature Coordinator
>>>>
>>>> _______________________________________________
>>>> Annotation mailing list
>>>> Annotation at geneontology.org
>>>> http://fafner.stanford.edu/mailman/listinfo/annotation
>>>>
>>>
>>
>> --
>> Doug Howe, Ph.D.
>> ZFIN Scientific Curator
>> Zebrafish Nomenclature Coordinator
>>
>> _______________________________________________
>> Annotation mailing list
>> Annotation at geneontology.org
>> http://fafner.stanford.edu/mailman/listinfo/annotation
>>
>
--
Doug Howe, Ph.D.
ZFIN Scientific Curator
Zebrafish Nomenclature Coordinator
More information about the Annotation
mailing list